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The gastrointestinal epithelial layer forms a physical and biochemical barrier that
maintains the segregation between host and intestinal microbiota. The integrity of this
barrier is critical in maintaining homeostasis in the body and its dysfunction is linked
to a variety of illnesses, especially inflammatory bowel disease. Gut microbes, and
particularly probiotic bacteria, modulate the barrier integrity by reducing gut permeability
and reinforcing tight junctions. Probiotic Escherichia coli Nissle 1917 (EcN) is a good
colonizer of the human gut with proven therapeutic efficacy in the remission of
ulcerative colitis in humans. EcN positively modulates the intestinal epithelial barrier
through upregulation and redistribution of the tight junction proteins ZO-1, ZO-2 and
claudin-14. Upregulation of claudin-14 has been attributed to the secreted protein
TcpC. Whether regulation of ZO-1 and ZO-2 is mediated by EcN secreted factors
remains unknown. The aim of this study was to explore whether outer membrane
vesicles (OMVs) released by EcN strengthen the epithelial barrier. This study includes
other E. coli strains of human intestinal origin that contain the tcpC gene, such as
ECOR63. Cell-free supernatants collected from the wild-type strains and from the
derived tcpC mutants were fractionated into isolated OMVs and soluble secreted
factors. The impact of these extracellular fractions on the epithelial barrier was evaluated
by measuring transepithelial resistance and expression of several tight junction proteins
in T-84 and Caco-2 polarized monolayers. Our results show that the strengthening
activity of EcN and ECOR63 does not exclusively depend on TcpC. Both OMVs and
soluble factors secreted by these strains promote upregulation of ZO-1 and claudin-14,
and down-regulation of claudin-2. The OMVs-mediated effects are TcpC-independent.
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Soluble secreted TcpC contributes to the upregulation of ZO-1 and claudin-14, but this
protein has no effect on the transcriptional regulation of claudin-2. Thus, in addition to
OMVs and TcpC, other active factors released by these microbiota strains contribute to
the reinforcement of the epithelial barrier.
Keywords: probiotics, gut microbes, Escherichia coli, phylogenetic group B2, membrane vesicles, tight junctions,
intestinal barrier, TcpC
INTRODUCTION
The gastrointestinal epithelial layer is the first line of defense
against pathogens and the surface where the host interacts
with microbiota. This specialized epithelium forms a physical
and biochemical barrier that maintains the segregation between
host and intestinal microbiota. Several factors contribute to the
epithelial barrier function, including the production of a mucin
layer that covers the epithelial surface and prevents direct contact
with intestinal microbes, the secretion of antimicrobial peptides,
and the establishment of TJ between intestinal epithelial cells
that seal the host tissue against the luminal environment. In
addition, intestinal epithelial cells play a key role in sensing and
integrating microbial signals that regulate the intestinal immune
cell responses (reviewed by Turner, 2009; Wells et al., 2011;
Peterson and Artis, 2014).
The TJ that connect adjacent intestinal epithelial cells are
composed of different types of integral membrane proteins such
as occludin, several claudins, tricellulin, and junctional adhesion
molecules (Turner, 2009). Organization of the TJ structure
depends on peripheral membrane proteins of the ZO family,
ZO-1, ZO-2, and ZO-3, which bind to claudins and act as
scaffolds anchoring the TJ transmembrane proteins to the actin
cytoskeleton (Umeda et al., 2006; Shen et al., 2011). Claudins are a
large family of TJ proteins that regulate paracellular permeability.
To date, 27 claudin isoforms have been identified in humans.
Some of them have a sealing function (like claudin-1), whereas
others act as selective channels or pores for small charged
molecules. Claudin-2, for instance, controls the movement of
ions and enhances transepithelial water flux (Rosenthal et al.,
2010).
The integrity of the epithelial barrier is critical in maintaining
homeostasis in the body and its dysfunction is linked to
inflammatory, allergic or metabolic diseases (Hering et al., 2012;
Oshima and Miwa, 2016). Interaction between gut microbiota
and the intestinal epithelium is crucial for the integrity of
this barrier. Alterations in microbiota composition or aberrant
responses to luminal bacteria or dietary components can result
in increased intestinal permeability, which may lead to the
development of such pathologies. In this context, many studies
have been conducted to investigate the therapeutic potential
of certain commensal and probiotic strains to ameliorate
Abbreviations: CF-SN, cell-free supernatant; COF-SN, cell-OMV-free
supernatant; DMEM, Dulbecco’s modified Eagle medium; EcN, Escherichia
coli Nissle 1917; FCS, fetal calf serum; LB, Luria-Bertani broth; OMVs, outer
membrane vesicles; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate
buffer saline; RT-qPCR, quantitative reverse transcription PCR; SDS, sodium
dodecyl sulfate; TER, transepithelial electrical resistance; TJ, tight junctions. ZO,
zonula occludens.
inflammatory bowel diseases in clinical trials (reviewed by
Chibbar and Dieleman, 2015; Wasilewski et al., 2015) or in
animal models of colitis (Ewaschuk et al., 2008; Arribas et al.,
2009; Shen et al., 2012; Kang et al., 2013; Martin et al., 2014;
Souza et al., 2016). In mice colitis models, beneficial bacteria
reduce inflammatory cytokines, normalize gut permeability, and
reinforce the epithelial barrier. Some studies indicate that these
effects may be mediated, at least in part, by bacterial secreted
factors (Ewaschuk et al., 2008; Martín et al., 2015) or by released
membrane vesicles (Shen et al., 2012; Kang et al., 2013).
Escherichia coli Nissle 1917 (EcN) is a Gram-negative
probiotic used to treat intestinal disorders, and particularly in
maintaining remission of ulcerative colitis (Kruis et al., 2004;
Chibbar and Dieleman, 2015). The strain, which was originally
isolated from a soldier who survived a severe outbreak of diarrhea
during the First World War, is a good colonizer of the human gut
and positively affects gastrointestinal homeostasis and microbiota
balance. It is well-known that EcN promotes anti-inflammatory
modulation of the immune response (Trebichavsky et al., 2010).
These effects have been mainly established from in vitro and
in vivo experiments performed with live probiotic suspensions.
We have recently shown that OMVs released by this probiotic can
modulate the cytokine/chemokine response of gut epithelial and
immune cells in in vitro and ex vivo cellular models (Fábrega et al.,
2016). The probiotic EcN also positively modulates the intestinal
epithelial barrier through both increased expression of secreted
antimicrobial factors such as β-defensin-2 (Schlee et al., 2007;
Fábrega et al., 2016) and upregulation and redistribution of the TJ
proteins ZO-1 (Ukena et al., 2007), ZO-2 (Zyrek et al., 2007), and
claudin-14 (Hering et al., 2014). Upregulation of claudin-14 in
HT-29/B6 cells has been attributed to TcpC (Hering et al., 2014),
an immunomodulatory protein secreted by uropathogenic E. coli
strains that interferes with the host immune defense by inhibiting
MyD88/Toll-like receptor 4 signaling cascade (Yadav et al., 2010;
Snyder et al., 2013). However, the bacterial factors that regulate
ZO-1 and ZO-2 expression have not been described to date.
Several facts indicate that the TJ strengthening capacity of
EcN is mediated by factors released to the extracellular medium:
(i) the TcpC activity on epithelial barrier function is associated
with EcN culture supernatants (Hering et al., 2014), and (ii) EcN
supernatants prevent barrier disruption by EPEC in polarized
Caco-2 cell monolayers and confer protection against deleterious
effects on paracellular permeability caused by virulence factors
such as the serin protease Sat (secreted autotransporter toxin)
(Toloza et al., 2015). The aim of this study was to define whether
the TJ-barrier strengthening capacity of EcN is mediated by
secreted factors or by OMVs using as a model T-84 and Caco-
2 polarized monolayers. We extended the analysis to other E. coli
strains of human intestinal origin from the reference collection
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(ECOR), and to the derived tcpC mutants. The activity of the
two extracellular fractions (OMVs and soluble secreted factors)
on the epithelial barrier function was evaluated by analyzing the
expression and subcellular location of several TJ proteins. We
show that both OMVs and soluble secreted factors from EcN
and ECOR63 promote upregulation of ZO-1 and claudin-14, and
down-regulation of claudin-2. The OMVs mediated effects are
TcpC-independent.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The probiotic strain EcN (serotype O6:K5:H1) was provided
by Ardeypharm (GmbH, Herdecke, Germany). ECOR12 and
ECOR63 are commensal E. coli strain isolated from healthy
human stool samples (Ochman and Selander, 1984). ECOR57,
from the same collection, was isolated from a healthy gorilla. EcN
tcpC::kan and ECOR63 tcpC::kan were constructed in this work
as described below. The laboratory E. coli strain HB101 (F− mcrB
mrr hsdS20 (rB− mB−) recA13 leuB6 ara-14 proA2 lacY1 galK2
xyl-5 mtl-1) was from the American Type Culture Collection
(ATCC 33694). The E. coli strains S17 (λpir) (Biomedal) and
EB6193 (RP4-2 tet Mu-1 kan::Tn7 integrant; leu-63::IS10 recA1
creC510 hsdR17 endA1 zbf-5 uidA(MuI)::pir+thi Spr/Smr) (de
la Riva et al., 2008) were used for cloning and propagation of
the suicide plasmid pUT-miniTn5 Tc and derived recombinant
constructs. Bacterial cells were grown at 37◦C in Luria–Bertani
broth (LB) or in DMEM (GIBCO) supplemented with 1% non-
essential amino acids and 25 mM HEPES, with constant rotation
(150 rpm). When required the following antibiotics were used
at the indicated concentrations: ampicillin (Ap), 100 µg/ml;
kanamycin (Km), 50 µg/ml; rifampicin (Rf), 50 µg/ml; and
tetracycline (Tc), 30 µg/ml. Growth was monitored by measuring
the optical density at 600 nm (OD600).
Site Directed Mutagenesis of tcpC Gene
To construct tcpC knockout mutants, a 2059 pb-fragment
encompassing the tcpC gene was amplified by PCR from
EcN genomic DNA using oligonucleotides FWKO-tcpC CGC
GGATCCGATGTCAGAAGCTTTACGAT and RVKO-tcpC
CCGGAATTCCTTGCCCATGAAATAGATCT. Restriction
sites for BamHI and EcoRI were incorporated at the 5′- ends
of the primers (underlined) to facilitate directed cloning of the
amplified fragment into plasmid pUC18Not (Biomedal).
Disruption of the cloned tcpC gene was performed by
insertion of the kan gene into the StuI site located 596 bp
downstream of the ATG codon. The kan cassette was obtained
by PCR amplification from plasmid pKD4 using primer Kn1
TCCCCCGGGGTGTAGGCTGGAGCTGCTTC and Kn2
TCCCCCGGGCATATGAATATCCTCCTTAG (Datsenko and
Wanner, 2000), with the SmaI restriction site incorporated
at their 5′-end (underlined). This process resulted in the
recombinant plasmid pUC18NotI-tcpC::kan.
The tcpC knockout mutant derived from EcN was generated
by antibiotic marker exchange using the suicide plasmid pUT-
miniTn5 Tc (Biomedal) as described previously (Toloza et al.,
2015). This vector contains the R6K origin of replication,
which functions only in bacteria that contain the gene pir.
The disrupted tcpC::kan gene was obtained by digestion of
the recombinant pUC18NotI-tcpC::kan plasmid with NotI and
further subcloned into the NotI restriction site of the suicide
plasmid pUT-miniTn5 Tc. The resulting recombinant plasmid
was propagated into strain EB6193 and introduced into E. coli
S17 (λpir) by electroporation, to be used as a donor strain in
mating experiments aimed at introducing the tcpC mutation
into the EcN chromosome. A Rf-resistant derivative of EcN
(Toloza et al., 2015) was used as the recipient. Transconjugants
were selected for their resistance to Km and Rf on LB plates
and further purified in this medium. After several rounds
of growth at 30◦C in this medium, colonies were screened
for sensitivity to Ap and Tc in order to identify which
transconjugants had undergone allelic exchange. Gene disruption
of the target gene was verified by PCR (Supplementary
Figure S1).
Since homologous recombination had not been successful
with ECOR63, the tcpC mutant derived from this strain was
constructed by the one-step inactivation method described
elsewhere (Datsenko and Wanner, 2000). In this case,
recombination requires the phage lambda Red recombinase,
which is synthesized under the control of an inducible promoter
on easily curable plasmid. We transformed ECOR63 with
pKD46 harboring a heat-labile origin and the gene encoding
the λRed recombinase under an arabinose-inducible promoter.
To construct the ECOR63 tcpC::kan mutant, wild-type strain
ECOR63 containing plasmid pKD46 was transformed with the
tcpC::kan fragment obtained by PCR from the recombinant
pUC18NotI-tcpC::kan, and grown in the presence of 100 mM
arabinose at 30◦C. Transformants were further grown at 37◦C
to loss the plamid. The ECOR63 tcpC::kan mutant was selected
by screening for Km resistance and Ap sensitivity. The correct
insertion of the mutation in the selected strain was confirmed by
PCR (Supplementary Figure S1).
Preparation of OMVs and Cell-Free
Supernatant Fractions
Cell free supernatants (CF-SN) were obtained from bacterial
cultures in LB medium or DMEM supplemented with 1% non-
essential aminoacids and 25 mM HEPES as described previously
(Toloza et al., 2015). Briefly, bacterial cells were pelleted by
centrifugation at 10,000 × g for 20 min at 4◦C; the supernatants
were filtered through a 0.22µm-pore-size filter (Merck Millipore)
to remove residual bacteria and concentrated using a Centricon R©
Plus-70 filter device with a molecular weight cutoff of 10 KDa
(Merck Millipore). OMVs were isolated from this CF-SN fraction
by ultracentrifugation at 150,000 × g for 1 h at 4◦C in an
OptimaTM L-90K ultracentrifuge (Beckman Coulter) as described
before (Aguilera et al., 2014). The supernatant obtained in this
step was concentrated twice and used as COF-SN fraction.
Pelleted OMVs were washed twice, resuspended in an adequate
volume of phosphate buffered saline (PBS) and stored at −20◦C.
Protein concentration was determined by the method of Lowry
et al. (1951).
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Cell Culture and Growth Conditions
The human colonic cells lines Caco-2 (ATCC HTB37) and T-84
(CCL-248) were obtained from the American Type Culture
Collection. The culture medium for Caco-2 cells was DMEM
High Glucose supplemented with 10% (v/v) FCS, whereas for
T-84 cells the medium was DMEM/F12 Glutamax medium
(Gibco-BRL) with 5% (v/v) FCS. In both cases, media contained
25 mM HEPES, 1% non-essential amino acids, penicillin
(100 U/ml) and streptomycin (100µg/ml) (Gibco-BRL). Cultures
were incubated at 37◦C with 5% CO2. Cells were routinely
subcultured once a week with trypsin-EDTA (Gibco-BRL) and
seeded at a density of 2 × 105 cells in 55 cm2 dishes (Caco-2)
or in 75 cm2 flasks (T-84) for propagation.
Transepithelial Resistance Measurement
T-84 cells (1 × 105 cells/cm2) were seeded on the apical
compartment of 12 mm polycarbonate Transwell cell culture
inserts (0.4 µm, Transwell Millipore). The basolateral
compartment contained 1.5 ml of the culture medium
supplemented with 10% (v/v) FCS, penicillin and streptomycin.
Cells were grown during 9 days. During growth and
differentiation the medium was changed every 2 days in
both compartments. Monolayer integrity was controlled by
measurement of the transepithelial electrical resistance (TER)
and by visual assessment of cell layer integrity under the
microscope. Prior to apical stimulation with OMVs or culture
supernatants (CF-SN or COF-SN), the medium was changed
to DMEM/F12 Glutamax containing 25 mM HEPES, 1%
non-essential amino acids, and gentamicin (100 µg/ml).
TER was measured with a Millicel-ERS-2 volt-ohmmeter
(Millipore). Before measurement, electrodes were equilibrated
and sterilized according to the manufacturer’s recommendations.
The ohmic resistance of a blank (culture insert without cells) was
measured in parallel. To obtain the sample resistance, the blank
value was subtracted from the total resistance of the sample. The
final unit area resistance (.cm2) was calculated by multiplying
the sample resistance () by the effective area of the membrane
(1.12 cm2).
Stimulations were performed at initial TER values greater
than 1000 .cm2. CF-SN (2 mg/ml), COF-SN (0.5 mg/ml), or
OMVs (0.1 mg/ml) were added to the apical compartment.
After incubation for 24 h at 37◦C, T-84 monolayers cells were
washed with PBS. TER was measured after 1 h stabilization in the
presence of fresh medium without FCS and antibiotics.
RNA Isolation and Quantitative Reverse
Transcription PCR (RT-qPCR)
T-84 (1 × 105 cells/cm2) and Caco-2 (0.5 × 105 cells/cm2) were
seeded on 12-well plates and cultured for 9 days. After 4 h
stimulation with COF-SN (0.5 mg/ml) or OMVs (0.1 mg/ml),
total RNA was extracted from epithelial cells by using the
Illustra RNAspin Mini kit (GE Healthcare) according to the
manufacturer’s instructions. The concentration and purity of
RNA samples were assessed by the ratio of the absorbance at 260
and 280 nm in a NanoDrop R© spectrophotometer. RNA integrity
was verified by visualization of 28S and 18S rRNAs after 1%
agarose/formaldehyde gel electrophoresis.
RNA (1 µg) was reverse transcribed using the High Capacity
cDNA Reverse Transcription kit (Applied Biosystems) in a final
volume of 20 µl following manufacturer’s recommendations. RT-
qPCR reactions were performed in a StepOne Plus PCR cycler
(Applied Biosystems) by using the Taqman Gene Expression
Master Mix, and the Taqman probes and primers for human
ZO-1, ZO-2, and occludin (Applied Biosystems), or SYBR R©
Green PCR master mix (Applied Biosystems) and specific
oligonucleotides for claudin-1 (Satake et al., 2008), claudin-2
(Zhang et al., 2013), and claudin-14 (BIORAD).
The standard PCR program used was: one denaturation cycle
for 10 min at 95◦C followed by 40 cycles of 15 s at 95◦C and 1 min
at 60◦C. A control reaction was performed in the absence of RNA.
The housekeeping gene β-actin was used as a normalizing gene.
Relative gene expression was calculated as fold-change compared
with control and calculated by means of 11Ct formula.
Immunoblotting of TJ Proteins
T-84 cells were grown for 9 days as indicated above for RNA
isolation. After 24 h stimulation with COF-SN or OMVs, cells
were rinsed in PBS and incubated with lysis buffer (50 mM
HEPES pH 7.4, 1% Triton X-100, 0.2% sodium deoxycholate,
0.1% SDS, 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA,
containing 20 µg/ml protease inhibitor cocktail) at 4◦C for
1 h. Then, cells were scraped off with a rubber policeman,
transferred to a chilled Eppendorf tube and homogenized for 40 s
whilst on ice using an electrical homogenizer. Samples were then
centrifuged at 20,800 × g for 15 min at 4◦C, and the supernatant
was collected and kept at−80◦C until use.
Proteins were separated on 10% SDS-PAGE, and transferred
to a Hybond-P polyvinylidene difluoride membrane by using a
Bio-Rad MiniTransblot apparatus. For ZO-1 analysis 7% SDS-
PAGE gels were used. The membrane was blocked in PBS-
0.05% Tween-20 and 5% skimmed milk (blocking solution) for
1 h at room temperature, and then incubated with specific
antibodies against ZO-1 (1:100 dilution), claudin-2 (1:1,000
dilution), occludin (1:1000 dilution) or β-actin (Sigma 1:10,000
dilution) for 16 h at 4◦C. The secondary antibody was donkey
anti-rabbit IgG conjugated to horseradish peroxidase, diluted
1:10,000 in blocking solution. β-Actin served as a loading control
to normalize protein expression levels. The protein-antibody
complex was visualized by using the ECL Plus Western blotting
detection system (Amersham Pharmacia Biotech). For protein
quantification, densitometry analysis was done with the software
package Image StudioTM Lite from LI-COR Biosciences.
Immunofluorescence Labeling
Caco-2 cells were grown for 5–7 days in an 8-well chamber
slide (µ-Slide 8 well Glass bottom, Ibidi). Then, cells were
stimulated with COF-SN (0.5 mg/ml) or OMVs (0.1 mg/ml)
for 24 h at 37◦C. After washing with PBS cells were fixed with
3% paraformaldehyde in PBS, permeabilized with 0.05% saponin
(Sigma–Aldrich) and blocked using PBS containing 1% bovine
serum albumin. The TJ proteins ZO-1, claudin-2 and occludin
were stained using, respectively, anti-ZO-1 (5 µg/ml, Invitrogen),
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anti-claudin-2 (5 µg/ml, Abcam) rabbit IgG antibodies, and anti-
occludin mouse IgG antibody (0.5 µg/ml, Invitrogen) for 16 h
at 4◦C, followed by incubation with Alexa Fluor 488-conjugated
F(ab’)2 goat anti-rabbit IgG (H+L) (5 µg/ml, Invitrogen) or
Alexa Fluor 488 - conjugated F(ab’)2 goat anti-mouse IgG (H+L)
(5 µg/ml, Invitrogen) for 2 h at 37◦C. Nuclei were labeled
with DAPI (0,125 µg/ml, Sigma–Aldrich) for 20 min at room
temperature.
Confocal Microscopy and Image
Analysis
Confocal microscopy was carried out using a Leica TCS SP2
confocal microscope equipped with an Ar, an Ar-UV and
a HeNe lasers. 12-bit images were obtained using a 63×
1.32NA oil immersion objective and an image resolution of
0.232 × 0.232 × 0.488 µm/voxel (x, y, z, respectively). Images
were analyzed using Fiji (Schindelin et al., 2012). For quantitative
analysis of ZO-1 and occludin, TJ were traced using the Tubeness
plugin and projected by maximum intensity projection. The
projected image was segmented using Li’s Minimum Cross
Entropy thresholding method (Li and Tam, 1998) and the
resulting segmented region of interest was used to measure mean
intensity in the maximum intensity projected original image
(Supplementary Figure S2).
Statistical Analysis
Statistical analysis was performed using SPSS (version 20.0,
Chicago, IL, USA) software package with pooled data from at
least three independent biological replicates. The values for all
measurements are presented as the mean ± standard error.
Differences between more than two groups were assessed using
one-way ANOVA followed by Tukey’s test. Significance was
stablished when p ≤ 0.05.
RESULTS
ECOR Strains That Contain the tcpC
Gene Increase TER in T-84 Monolayers
The positive effects of the probiotic EcN on intestinal barrier
function have been attributed to TcpC, a protein that mediates
upregulation of the TJ protein claudin-14 (Hering et al., 2014).
To search for other intestinal E. coli strains with TJ-barrier-
strengthening ability, we screened the ECOR collection (Ochman
and Selander, 1984) for the presence of tcpC sequences. Using
the information available at NCBI1 we identified five tcpC-
positive ECOR strains, namely ECOR53, 56, 57, 60, and 63
(Schubert et al., 2010). Like EcN, all of the strains belong to the
phylogenetic group B2, associated with virulent strains that cause
extra-intestinal infections. ECOR53 and ECOR63 were isolated
from healthy human stools, whereas ECOR56 and ECOR60 were
isolated from patients with urinary tract infection. ECOR57
was from a healthy gorilla (STEC Center)2. Studies to identify
1http://www.ncbi.nlm.nih.gov
2http://www.shigatox.net/new/reference-strains/ecor.html
potential virulence markers among the ECOR strains showed
that all of these strains, except ECOR57 and ECOR63, expressed
functional haemolysin and caused strong cytotoxicity in the
murine macrophage cell line J774 (Lai et al., 1999). With this
information, we excluded the cytotoxic strains from this study.
We previously showed that EcN CF-SN have a positive impact
on the TER of epithelial cell monolayers and prevent barrier
disruption caused by pathogens (Toloza et al., 2015). To test the
ability of tcpC-positive strains ECOR63 and ECOR57 to strength
the epithelial barrier, T-84 monolayers were incubated for 24 h
with CF-SN (2 mg/ml) collected from LB cultures, and TER
was measured before and after the treatment period. CF-SN
obtained from EcN cultures (positive control) or from HB101
(negative control) were processed in parallel. We also included
the intestinal isolate ECOR12 (tcpC-negative) for comparison.
Only the tcpC-positive strains increased TER, whereas the
laboratory strain HB101 or the commensal ECOR12 had no effect
on this parameter (Figure 1). These results are in accordance
with those reported by Hering et al. (2014). As ECOR57 is not
of human origin we selected ECOR63 for further studies.
The Positive Effects of EcN and ECOR63
on TER Are Mediated by Soluble and
Vesicle-Associated Factors
Since no information was available on the mechanism of TcpC
secretion, we sought to analyze whether the TcpC effect was
associated with OMVs. For this approach, we constructed tcpC
mutants derived from both EcN and ECOR63 strains. These
mutants, as well as the parental wild-type strains, were grown
FIGURE 1 | Escherichia coli reference collection (ECOR) strains
bearing tcpC gene increase TER in T-84 cell monolayers. The effect on
TER of the indicated Escherichia coli strains from the ECOR collection was
analyzed in T-84 monolayers in comparison with the probiotic EcN and the
laboratory strain HB101. TER values were measured before and after 24 h
incubation with cell-free supernatants (CF-SN) (2 mg protein/ml) collected
from LB cultures (n = 3 independent biological replicates). Data are presented
as percentage of increase in TER from the initial value. asignificance against
untreated control cells (p ≤ 0.001).
Frontiers in Microbiology | www.frontiersin.org 5 December 2016 | Volume 7 | Article 1981
fmicb-07-01981 December 14, 2016 Time: 11:33 # 6
Alvarez et al. Microbiota-OMVs Modulate Epithelial Tight Junctions
overnight in LB. Cultures were centrifuged and the supernatant
was filtered to eliminate bacteria and obtain the corresponding
CF-SN samples. An aliquot of each CF-SN was centrifuged at
150,000 × g for 1 h to isolate OMVs. The potential of these
fractions to stimulate TER was analyzed on T-84 cell monolayers
after 24 h incubation (Figure 2A). Regarding the probiotic EcN,
the tcpC mutation significantly diminished the capacity of CF-
SN to increase TER values. In contrast, CF-SN collected from the
ECOR63 tcpC mutant increased TER to levels comparable to the
wild-type strain. Analysis of TER in monolayers challenged with
bacterial OMVs (0.1 mg/ml) revealed the potential of EcN and
ECOR63 vesicles to increase TER. For both strains, this effect was
TcpC- independent.
Protein components of the rich LB medium interfere with
the protein quantification of CF-SN samples. Therefore, to better
analyze the effect of released soluble mediators on TER, wild-
type EcN and ECOR63, and the derived tcpC mutants were
grown in DMEM. After 8 h growth (exponential phase), cells
were removed by centrifugation and the CF-SN were processed to
isolate OMVs from the secreted soluble fraction (COF-SN). The
potential of these fractions to stimulate TER was analyzed on T-
84 cell monolayers after 24 h incubation (Figure 2B). The results
obtained after stimulation with OMVs (0.1 mg/ml) or COF-SN
(0.5 mg/ml) collected from DMEM cultures were comparable
to those achieved with samples isolated from LB cultures.
Introduction of the tcpC mutation only significantly diminished
the barrier strengthening capacity of COF-SN from EcN. Overall,
these results indicate that both soluble and vesicle-associated
factors mediate the positive effects of EcN and ECOR63 on TER.
Moreover, they suggest that TcpC secretion is not associated
with OMVs, and that, in addition to TcpC, commensal ECOR63
releases other factors that can modulate the strength of the
epithelial barrier.
Expression Analysis of TJ Proteins in
Intestinal Epithelial Cells Challenged
with OMVs or Soluble Factors Released
by EcN and ECOR63
As the observed effects on TER pointed to changes in TJ
proteins, expression of genes encoding several barrier-relevant TJ
proteins was analyzed in T-84 cells. In this study, we included
proteins known to be regulated by the probiotic EcN, such as
ZO-1, ZO-2, and claudin-14 (Ukena et al., 2007; Zyrek et al.,
2007; Hering et al., 2014), and others like occludin, claudin-1
and claudin-2. T-84 monolayers (9 days post-confluence) were
apically stimulated for 4 h with OMVs (0.1 mg/ml) or COF-
SN (0.5 mg/ml) collected from exponential DMEM cultures
of the two wild-type strains EcN and ECOR63, and from the
tcpC mutants. Untreated monolayers served as a control. The
mRNA levels of the indicated TJ proteins were measured by RT-
qPCR (Figure 3A). The results show transcriptional regulation
of ZO-1, claudin-2, and claudin-14 by the two types of bacterial
samples (OMVs and COF-SN) from either EcN or ECOR63.
Specifically they promoted upregulation of ZO-1 and claudin-
14, and downregulation of claudin-2 (Figure 3A, plain bars).
In contrast, mRNA levels of ZO-2, occludin and claudin-1
FIGURE 2 | The impact of ECOR63 and EcN on TER depends on both
released soluble factors and OMVs. (A) TER analysis of T-84 monolayers
after 24 h incubation with CF-SN (2 mg/ml) (containing both released soluble
mediators and OMVs) or isolated OMVs (0.1 mg/ml) from overnight cultures in
LB medium of the wild-type strains EcN (white bars) and ECOR63 (gray bars)
and from their corresponding tcpC mutants (doted bars). (B) TER analysis of
T-84 monolayers after 24 h incubation with COF-SN (0.5 mg/ml) (containing
only released soluble mediators) or isolated OMVs (0.1 mg/ml) from DMEM
exponential cultures of the same wild-type strains (plain bars) and tcpC
mutants (doted bars). In both panels, data are presented as changes in TER
(%) from the initial value (n = 3 independent biological replicates).
asignificance against untreated control cells (p ≤ 0.05); bsignificance tcpC
mutant vs. wild-type (p ≤ 0.002).
were not significantly altered under any incubation condition,
as their mRNA levels remained similar to those of control
monolayers.
Regarding the effect of COF-SN, upregulation of ZO-1 and
claudin-14 was almost abolished by TcpC deficiency in EcN, and
significantly weakened in the case of ECOR63 tcpC (Figure 3A,
dotted bars). These results show that TcpC contributes to the
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FIGURE 3 | Gene expression levels of tight junction proteins in the intestinal epithelial cell lines T-84 (A) or Caco-2 (B). Cell monolayers were challenged
for 4 h with COF-SN (0.5 mg/ml) or OMVs (0.1 mg/ml) from EcN (white bars), EcN tcpC::kan (doted white bars), ECOR63 (gray bars) or ECOR63 tcpC::kan (doted
gray bars). Relative mRNA levels of the indicated proteins were measured by RT-qPCR, using β-actin as the reference gene. Data are presented as fold-change
compared to untreated control cells (n = 3 independent biological replicates). aSignificance against untreated control cells (p ≤ 0.04); bsignificance tcpC mutant vs.
wild-type (p ≤ 0.02).
transcriptional regulation of ZO-1 and claudin-14, and suggest
that other released factors may contribute to this regulation
in ECOR63. In contrast, TcpC deficiency did not result in
noticeable changes in claudin-2 mRNA levels compared to
COF-SN collected from wild-type EcN and ECOR63, thus
ruling out the contribution of TcpC to the transcriptional
control of claudin-2. Considering the effect of OMVs, no
significant differences in the mRNA levels of ZO-1, claudin-2 or
claudin-14 were observed between cells stimulated with OMV
samples isolated either from the wild-type or the tcpC mutants
(Figure 3A).
The expression of TJ proteins was also analyzed in Caco-2
monolayers. In general, the results show a similar transcriptional
pattern, that is, upregulation of ZO-1 and claudin-14, and
down-regulation of claudin-2 (Figure 3B). As in T-84 cells,
transcriptional regulation of these proteins by OMVs was not
affected by the tcpC mutation, but the relative mRNA levels
of ZO-1 and claudin-14 were lower in Caco-2 cells (below 2-
fold). Regarding stimulations with COF-SN, expression of ZO-1
and claudin-2 followed the same pattern as in T-84 cells. It
was noticeable that the effect of COF-SN from ECOR63 and
ECOR63 tcpC on ZO-1 expression was clearly lower than in
the T-84 cell line, with relative mRNA levels that were around
50% of those achieved in T-84 monolayers (Figure 3). The lower
response of Caco-2 cells to ECOR63 COF-SN could explain the
lack of claudin-14 induction in this cell line. A 50% reduction
in the relative claudin-14 mRNA levels observed in T-84 cells
challenged with ECOR63 COF-SN (Figure 3A) may correlate in
Caco-2 cells with mRNA levels close to those of untreated cells
(Figure 3B).
We next undertook Western blot experiments to assess
the regulation of ZO-1 and claudin-2 expression by soluble
and vesicle-associated factors secreted by EcN and ECOR63.
Occludin expression was analyzed as a control of a non-regulated
Frontiers in Microbiology | www.frontiersin.org 7 December 2016 | Volume 7 | Article 1981
fmicb-07-01981 December 14, 2016 Time: 11:33 # 8
Alvarez et al. Microbiota-OMVs Modulate Epithelial Tight Junctions
FIGURE 4 | Western blot analysis of TJ proteins in T-84 cell monolayers
treated with COF-SN or OMVs from the indicated bacterial strains.
(Continued)
FIGURE 4 | Continued
Cell monolayers were challenged for 24 h with COF-SN (0.5 mg/ml) or
OMVs (0.1 mg/ml) from EcN (white bars), EcN tcpC::kan (doted white
bars), ECOR63 (gray bars) or ECOR63 tcpC::kan (doted gray bars).
Occludin, ZO-1 and claudin-2 were immunodetected with specific antibodies.
(A) Representative Western blots of three independent experiments are
shown. (B) Densitometric quantification of the TJ proteins (n = 3 independent
biological replicates). Values were normalized to β-actin. Normalized values
from untreated control cells were set as 100% and indicated by a dashed
line. aSignificance against untreated control cells (p ≤ 0.04); bsignificance tcpC
mutant vs. wild-type (p = 0.001).
protein. Immunoblotting analysis was performed in T-84 cell
monolayers after 24 h incubation with extracellular samples
from both wild-type and tcpC mutant strains (Figure 4).
Densitometry quantification and normalization to β-actin
confirmed downregulation of claudin-2 by all samples, with a
30–40% reduction in claudin-2 levels compared to the untreated
control (Figure 4B). Regarding ZO-1, the results depend on
whether T-84 cells were incubated with COF-SN or OMVs.
Significant increases in ZO-1 were observed in cells treated
with either wild-type EcN or ECOR63 COF-SNs. As expected,
in cells incubated with COF-SN from the EcN tcpC mutant,
ZO-1 protein levels did not significantly differ from those of
untreated control cells. However, although ZO-1 levels achieved
upon stimulation with supernatants from the ECOR63 tcpC
mutant were slightly lower, they did not significantly differ
from those of cells incubated with supernatants from the wild-
type strain. Consistent with RT-qPCR data, OMVs triggered a
significant increase in ZO-1 protein levels independently of the
producer strain (Figure 4B). Quantification of occludin levels
also confirmed that expression of this protein remained similar
to those of untreated monolayers.
Immunofluorescence Microscopy
Analysis of TJ Confirm Regulation of
ZO-1 and Claudin-2 by Factors Secreted
by EcN and ECOR63
To confirm the impact of TcpC and other soluble and vesicle-
secreted factors on TJ, we carried out immunofluorescence
staining, followed by confocal laser scanning microscopy of ZO-
1 and claudin-2. Occludin was analyzed in parallel as a control
of a non-regulated protein. This analysis was performed in
Caco-2 monolayers challenged for 24 h with COF-SN or OMVs
isolated from wild-type EcN and ECOR63 and the derived tcpC
mutants. Untreated Caco-2 cells and Caco-2 cells incubated
with samples collected from ECOR12, which did not exhibit
the ability to strengthen the epithelial barrier, were processed
in parallel as a control. After 24 h incubation, cells were fixed
and stained for the indicated proteins. Representative images are
presented in Figure 5 (for occludin and claudin-2) and Figure 6
(for ZO-1). As expected, no differences in the fluorescence
signal of any of the three proteins were observed in cells
treated with ECOR12 samples with respect to the untreated
control cells. The results for cells incubated with EcN and
ECOR63 samples correlated with mRNA and protein expression
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FIGURE 5 | Immunofluorescence staining for occludin and claudin-2 in Caco-2 cells treated for 24 h with COF-SN or OMVs from the indicated
bacterial strains. Immunostaining of occludin (left) and claudin-2 (right) was carried out in Caco-2 cells at 5 days after seeding (n = 3 independent biological
replicates). Images are color coded with Fire look-up table and its calibration bar is shown on the right. Scale bar, 20 µm.
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FIGURE 6 | Immunofluorescence staining for ZO-1 in Caco-2 cells treated for 24 h with COF-SN or OMVs from the indicated bacterial strains.
(A) Immunostaining of ZO-1 was carried out in Caco-2 cells at 5 days after seeding. Images are color coded with Fire look-up table and its calibration bar is shown
on the right. Scale bar, 20 µm. (B) Quantification of the mean fluorescence intensity of ZO-1 labeling in tight junctions. See Supplementary Figure S2 for details in
the tracing and processing of the images. Data are presented as mean ± SEM of relative intensity units (IU) (n = 5 independent biological replicates for COF-SN
treated cells and n = 3 independent biological replicates for OMVs treated cells). Statistical differences were assessed by the t-test. aSignificance against untreated
control cells (p < 0.015); bsignificance tcpC mutant vs. wild-type (p ≤ 0.05).
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data. Consistently, no significant treatment-associated changes
were observed for occludin, whereas the claudin-2 signal was
diminished in cells treated with either COF-SN or OMVs isolated
from EcN and ECOR63, independently of whether they were
positive or negative for TcpC (Figure 5). Notice that the claudin-
2 signal was mainly localized in the cytoplasm. Since our analysis
was performed in cells grown for 7 days, this observation is
consistent with results from a time course analysis of claudin-2
immunofluorescence staining in Caco-2 cells, reported elsewhere
(Fisher et al., 2014). After 3 days of cell seeding, the claudin-
2 signal appeared to be diffusely distributed in the cytoplasm,
whereas the progressive location of claudin-2 along TJ could
be observed later during cell differentiation, such as at 21 days
(Fisher et al., 2014). Concerning the upregulated ZO-1 protein,
microscopy images showed an increased signal in the cell
boundaries of Caco-2 monolayers treated with wild-type EcN
or ECOR63 COF-SN, whereas this increase was not apparent
in cells incubated with COF-SN collected from cultures of the
tcpC mutants. In this case, ZO-1 signals were similar to those of
control cells (Figure 6A). OMVs isolated from EcN and ECOR63
also promoted an increase in the peripheral ZO-1 signal, and this
effect was not abolished by the tcpC mutation (Figure 6A).
The ZO-1 signal was quantified in TJ, as described
in the section “Materials and Methods” and illustrated in
Supplementary Figure S2. The results presented in Figure 6B
reveal a statistically significant increase in TJ ZO-1 after
treatment with COF-SN from EcN and ECOR63, but not after
incubation with supernatants from the derived tcpC mutants
(data collected from five independent biological experiments,
mean of total cells analyzed for each experiment = 94 ± 6.16).
Quantification analysis also confirmed that the ZO-1 increase
triggered by EcN or ECOR63 OMVs was TcpC-independent
(data collected from three independent biological experiments,
mean of total cells analyzed in each experiment = 104 ± 15.30).
Quantification of the occludin signal using the same software
ruled out significant changes in the junctional localization of this
protein between treated and untreated cells. The analysis of three
independent replicates with a mean of 127.26 ± 28.43 cells per
experiment yielded arbitrary intensity units around 500–600 for
all conditions (not shown).
DISCUSSION
It is now well-known that gut microbiota is a source of regulatory
signals that influence the maturation and function of the
digestive and immune systems. In this context, the intestinal tract
requires barrier and regulatory mechanisms to control reciprocal
interactions between commensal bacteria, the epithelium and the
mucosal immune system that prevent aberrant responses and
preserve homeostasis. Conditions that compromise the integrity
of the epithelial barrier are the basis of a wide range of illnesses,
with special impact on inflammatory bowel diseases. As certain
commensal bacteria modulate the integrity of the epithelial
barrier, potential clinical applications of gut microbes are being
explored to reduce increased intestinal permeability and improve
the clinical status of such gastrointestinal diseases. Besides
anti-inflammatory effects, upregulation and redistribution of TJ
proteins are among the multiple mechanisms used by these
microbes to improve the epithelial barrier function. The probiotic
EcN is a good intestinal colonizer that has been licensed for use in
human medicine to treat several disorders of the gastrointestinal
tract. Its therapeutic efficacy in the remission of ulcerative colitis
has been proved through clinical trials (Kruis et al., 2004;
reviewed by Scaldaferri et al., 2016). In addition, the effectiveness
of this probiotic in the amelioration of induced experimental
colitis in mice is well-documented (Grabig et al., 2006; Ukena
et al., 2007; Garrido-Mesa et al., 2011; Olier et al., 2012; Souza
et al., 2016). The ability of EcN to decrease intestinal permeability
and cure leaky gut may be attributed, at least in part, to its
ability to strength TJ. In vivo upregulation of ZO-1 by EcN
suspensions was evidenced in both healthy and dextran sodium
sulfate-treated mice (Ukena et al., 2007), whereas in vitro studies
showed upregulation of ZO-2 (Zyrek et al., 2007) or claudin-14
(Hering et al., 2014), depending on the epithelial cell line used.
In the gut, communication between microbiota and the host
mainly relies on secreted factors that can go through the mucus
layer and reach the epithelium. Thus, membrane vesicles released
by commensal strains are emerging as key players in signaling
processes in the intestinal mucosa. We have recently shown that
EcN OMVs, as well as vesicles produced by other commensal
E. coli strains, are internalized by epithelial cells through clathrin-
mediated endocytosis (Cañas et al., 2016) and mediate signaling
events to the immune system through the intestinal epithelial
barrier (Fábrega et al., 2016). Here we aim to analyze the impact
of EcN OMVs on the integrity of the intestinal epithelial barrier.
In HT-29/B6 monolayers, the TER increase and upregulation
of claudin-14 by EcN was attributed to TcpC, a secreted protein
present in the culture supernatant. No other regulatory effects
on TJ proteins were apparent in this cellular model (Hering
et al., 2014). Upon removal of bacteria, culture supernatants
contained both OMVs and soluble factors. Thus, we isolated the
released vesicles from the putative active factors secreted in a
soluble form (COF-SN), and tested both extracellular fractions
independently. We extended our study to other tcpC-positive
E. coli strains from the ECOR reference collection, and confirmed
that their culture supernatants stimulated TER in T-84 cell
monolayers. Like EcN, these tcpC-positive isolates fit into the
phylogenetic group B2, which is associated with virulent strains
that cause extra-intestinal infections. In fact, TcpC is highly
prevalent in Gram-negative pathogens. This protein contains
a Toll/IL-1 receptor (TIR)-binding domain, which mediates its
interaction with Myd88 and inhibits toll-like receptor signaling
pathways. By this mechanism, TcpC impairs innate immunity,
causing inflammation and tissue damage (Cirl et al., 2008;
Yadav et al., 2010). However, in spite of its virulent nature,
TcpC have a positive impact on the epithelial barrier (Hering
et al., 2014). TcpC, like the immunomodulin colibactin, are
among the virulence factors encoded in the EcN genome that
contribute to its probiotic activity. Colibactin is a non-ribosomal
peptide-polyketide synthesized by enzymes encoded in the pks
island, which displays both genotoxic and anti-inflammatory
effects. Mutations that abolish colibactin synthesis greatly reduce
the beneficial activity of EcN in the modulation of cytokine
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expression and amelioration of experimental colitis in mice
(Olier et al., 2012). The prevalence of extraintestinal virulence
determinants in commensal E. coli B2 isolates has been explained
on the basis that these determinants are in fact survival factors
that can increase the fitness of the strains within the normal gut
environment (Le Gall et al., 2007).
Our results showed that the strengthening activity of EcN
and ECOR63 (the selected tcpC-positive strain lacking cytotoxic
activity) does not exclusively depend on TcpC. Several facts point
to the contribution of other bacterial effectors. First, partition of
the culture supernatants revealed that both OMVs and soluble
factors (COF-SN) collected from these strains increased the TER
of T-84 cell monolayers upon 24 h incubation. Second, TcpC
deficiency did not alter the OMV-stimulatory activity, and only
diminished the effect of COF-SN collected from EcN. Overall,
these results show for the first time the ability of secreted
microbiota vesicles to modulate the integrity of the epithelial
barrier, and also indicate that TcpC is not exported through
OMVs. In addition, they reveal that these strains, especially
ECOR63, secrete soluble active factors other than TcpC that have
a great impact on the epithelial barrier.
Quantitative reverse transcription PCR analyses were
undertaken to evaluate the capacity of these soluble and
vesicular-secreted fractions to regulate the expression of selected
TJ proteins. Neither OMVs nor COF-SN from the two strains
triggered significant changes in the mRNA levels of ZO-2,
occludin or claudin-1. Regarding ZO-2, studies performed in
the same cellular models used here (T-84 and Caco-2 cells)
revealed upregulation of this protein upon incubation with
EcN suspensions (Zyrek et al., 2007). As we stimulated the
epithelial cell monolayers with secreted EcN fractions, we may
speculate that EcN-mediated upregulation of ZO-2 depends on
bacteria-associated factors. Concerning the other genes analyzed
in this study, our results showed upregulation of claudin-14 and
ZO-1, and downregulation of claudin-2. Interestingly, all these
effects were mediated either by OMVs or COF-SN collected from
the two strains.
Regarding claudin-14, upregulation of this protein by COF-
SN samples was in agreement with the literature on EcN
supernatants, as this effect mainly relies on TcpC (Hering et al.,
2014). Nevertheless, in ECOR63, TcpC deficiency did not result
in a significant reduction of claudin-14 mRNA levels, at least
in the T-84 cellular model. This confirms the presence of other
active soluble factors in the COF-SN samples from ECOR63.
Moreover, OMVs isolated from both EcN and ECOR63 strains
also triggered upregulation of claudin-14 in a TcpC-independent
manner.
In the case of ZO-1, our results indicate that the in vivo
upregulation of this protein by EcN (Ukena et al., 2007) may
be attributed to TcpC and released OMVs. Here, expression of
this protein was analyzed at both mRNA and protein levels.
In all conditions tested, ZO-1 protein quantified by Western
blot correlated well with the corresponding mRNA levels, which
points to transcriptional regulation of the gene. As expected,
upregulation of ZO-1 by bacterial OMVs did not depend on
TcpC. Regarding the activating activity of COF-SN samples, the
results differed depending on the strain. In EcN, upregulation of
ZO-1 by COF-SN depends on TcpC exclusively, but in ECOR63
other soluble secreted factors existing in the corresponding
sample could contribute to modulating ZO-1 expression. Notice
that ZO-1 mRNA levels in T-84 cells treated with COF-SN from
ECOR63 tcpC::kan were still significantly higher than those of
untreated controls. Immunofluorescence staining followed by
confocal laser scanning microscopy evidenced enhanced ZO-1
staining in the cell boundaries of monolayers treated with EcN
or ECOR63 samples, but not in cells incubated with ECOR12
samples. In stimulated Caco-2 monolayers, enhanced expression
of ZO-1 correlates with an increased TJ-associated ZO-1 signal,
except for cells treated with COF-SN collected from the ECOR63
tcp mutant. In this case, the increase in TJ-associated ZO-1 signal
was not statistically significant.
In addition to TJ proteins that are known to be regulated
by EcN, in this study we included the leaky protein claudin-
2, which plays an opposing role to other TJ proteins. This is a
pore-forming protein that facilitates cation and water secretion
by epithelial cells. Stimuli that raise claudin-2 levels result in
increased barrier permeability (Luetting et al., 2015). Increased
expression of claudin-2 has been reported in the gut epithelia
of patients with ulcerative colitis and Crohn’s disease (Hering
et al., 2012; Landy et al., 2016). Pathogens like Salmonella
increase claudin-2 expression to facilitate bacterial invasion
(Zhang et al., 2013). Microbial toxins, such as cholera toxin
or Staphylococcal enterotoxin B, also promote upregulation of
claudin-2, and thus compromise the intestinal epithelial barrier
(Liu et al., 2013). In contrast, downregulation of claudin-2 is part
of the mechanism used by some probiotic strains to enhance
the intestinal barrier function (Ewaschuk et al., 2008). Our
study shows for the first time the capacity of EcN to decrease
claudin-2 expression. By means of gene and protein expression
analyses, we provide evidence that downregulation of claudin-
2 by EcN is mediated by released OMVs as well as by soluble
factors, other than TcpC. In addition to the known effects of
EcN on expression of the sealing TJ proteins ZO-1 and claudin-
14, downregulation of claudin-2 can contribute to the efficacy
of this probiotic in the treatment of intestinal infections and
inflammatory diseases. Secreted OMVs and microbial factors
from ECOR63, which belongs to the phylogenetic group B2 like
EcN, also decrease claudin-2 expression. However, commensal
ECOR12 (phylogenetic group A), which does not reinforce
the TER of the epithelial barrier, does not modulate claudin-2
expression.
CONCLUSION
This study addresses the impact of bacterial secreted factors on
the expression of TJ proteins that are known to be regulated by
EcN, as well as other proteins described here for the first time,
like claudin-2. To the best of our knowledge, this is the first
study providing evidence that OMVs from certain commensal
E. coli strains, specifically EcN and ECOR63, increase epithelial
barrier function through upregulation of ZO-1 and claudin-
14, and downregulation of the leaky protein claudin-2. These
regulatory effects are not mediated by TcpC. We have previously
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reported that OMVs released by the probiotic EcN induce IL-
22 expression in colonic explants (Fábrega et al., 2016). This
cytokine, mainly expressed by immune cells, targets epithelial
cells and reinforces the intestinal barrier, thus limiting the access
of microbial compounds and allergens to the systemic circulation.
Thus, our studies show that OMVs contribute to reinforcing
the epithelial barrier integrity directly through transcriptional
regulation of TJ proteins and indirectly through regulation of
IL-22.
Besides OMVs, the soluble secreted TcpC protein also
contributes to the upregulation effect of ZO-1 and claudin-14.
In contrast, this protein has no effect on the transcriptional
regulation of claudin-2. Thus, these microbiota strains release
other bioactive factors that contribute to the reinforcement of the
epithelial barrier.
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FIGURE S1 | PCR confirmation of gene disruption in EcN tcpC::kan and
ECOR63 tcpC::kan mutants. PCR amplification of tcpC sequences with primers
FW-tcpC (TCGCATGGAAACAGCACCT) and RV-tcpC (CTTCTCCTGTATGCTAT
TTCAGC) in the indicated strains. The size of the amplified products is indicated.
The 1.6 Kb-increase in the PCR product from knockout mutants corresponds to
the kanamycin cassette inserted inside tcpC gene. The size marker was lambda
HindIII.
FIGURE S2 | Image analysis of tight junction stained with ZO-1. (A) Inset of
an original image. (B) Same inset after processing by median filter, subtract
background and tracing using the Tubeness plugin. (C) Regions of interest (ROIs,
green) obtained after binarizing (B) by applying Li’s Minimum Cross Entropy
thresholding method. (D) Overlap of ROIs in (C) on the original image (A). Images
are color coded with Fire look-up table. Scale bar, 20 µm.
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